maximus inc. - MMS

MMS

Close Chg Chg %
87.06 -0.22 -0.25%

Closed Market

86.84

-0.22 (0.25%)

Volume: 189.23K

Last Updated:

Dec 24, 2025, 12:59 PM EDT

Company Overview: maximus inc. - MMS

MMS Key Data

Open

$87.32

Day Range

86.31 - 87.56

52 Week Range

63.77 - 92.50

Market Cap

$4.74B

Shares Outstanding

54.46M

Public Float

53.46M

Beta

0.55

Rev. Per Employee

N/A

P/E Ratio

15.78

EPS

$5.59

Yield

138.03%

Dividend

$0.30

EX-DIVIDEND DATE

Nov 14, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

675.71K

 

MMS Performance

1 Week
 
-1.31%
 
1 Month
 
0.99%
 
3 Months
 
-1.34%
 
1 Year
 
19.23%
 
5 Years
 
19.36%
 

MMS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About maximus inc. - MMS

MAXIMUS, Inc. engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S. state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions and includes appeals and assessment services, system and application development, IT modernization, and maintenance services. The Outside the U.S segment provides BPS for international governments and commercial clients. The company was founded by David V. Mastran in 1975 and is headquartered in McLean, VA.

MMS At a Glance

MAXIMUS, Inc.
1600 Tysons Boulevard
McLean, Virginia 22102
Phone 1-703-251-8500 Revenue 5.43B
Industry Miscellaneous Commercial Services Net Income 319.03M
Sector Commercial Services 2025 Sales Growth 2.357%
Fiscal Year-end 09 / 2026 Employees 37,200
View SEC Filings

MMS Valuation

P/E Current 16.024
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 16.588
Price to Sales Ratio 0.974
Price to Book Ratio 2.991
Price to Cash Flow Ratio 12.33
Enterprise Value to EBITDA 9.225
Enterprise Value to Sales 1.192
Total Debt to Enterprise Value 0.223

MMS Efficiency

Revenue/Employee 146,002.043
Income Per Employee 8,576.183
Receivables Turnover 6.021
Total Asset Turnover 1.325

MMS Liquidity

Current Ratio 1.637
Quick Ratio 1.637
Cash Ratio 0.34

MMS Profitability

Gross Margin 22.856
Operating Margin 10.463
Pretax Margin 8.191
Net Margin 5.874
Return on Assets 7.78
Return on Equity 18.143
Return on Total Capital 10.231
Return on Invested Capital 10.531

MMS Capital Structure

Total Debt to Total Equity 86.269
Total Debt to Total Capital 46.314
Total Debt to Total Assets 35.486
Long-Term Debt to Equity 80.816
Long-Term Debt to Total Capital 43.387
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Maximus Inc. - MMS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
4.63B 4.90B 5.31B 5.43B
Sales Growth
+8.85% +5.91% +8.19% +2.36%
Cost of Goods Sold (COGS) incl D&A
3.78B 3.97B 4.15B 4.19B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
141.69M 162.02M 135.33M 133.72M
Depreciation
28.23M 28.43M 19.16M 19.47M
Amortization of Intangibles
104.56M 120.89M 106.37M 114.25M
COGS Growth
+12.82% +5.00% +4.42% +1.06%
Gross Income
849.35M 934.02M 1.16B 1.24B
Gross Income Growth
-5.90% +9.97% +24.20% +7.01%
Gross Profit Margin
+18.34% +19.04% +21.86% +22.86%
2022 2023 2024 2025 5-year trend
SG&A Expense
537.56M 638.65M 668.37M 673.13M
Research & Development
- - - -
-
Other SG&A
537.56M 638.65M 668.37M 673.13M
SGA Growth
+11.23% +18.80% +4.65% +0.71%
Other Operating Expense
- - - -
-
Unusual Expense
(3.07M) 575.00K 3.22M 427.00K
EBIT after Unusual Expense
314.85M 294.79M 488.50M 567.84M
Non Operating Income/Expense
8.21M (363.00K) 450.00K (47.40M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
45.97M 84.14M 82.44M 75.59M
Interest Expense Growth
+211.75% +83.05% -2.02% -8.31%
Gross Interest Expense
45.97M 84.14M 82.44M 75.59M
Interest Capitalized
- - - -
-
Pretax Income
277.10M 210.29M 406.51M 444.85M
Pretax Income Growth
-27.78% -24.11% +93.31% +9.43%
Pretax Margin
+5.98% +4.29% +7.66% +8.19%
Income Tax
73.27M 48.50M 99.59M 125.81M
Income Tax - Current - Domestic
60.41M 46.37M 109.83M 127.69M
Income Tax - Current - Foreign
2.65M 584.00K 25.79M 14.84M
Income Tax - Deferred - Domestic
9.24M (2.17M) (21.79M) (15.36M)
Income Tax - Deferred - Foreign
967.00K 3.72M (14.23M) (1.36M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
203.83M 161.79M 306.91M 319.03M
Minority Interest Expense
- - - -
-
Net Income
203.83M 161.79M 306.91M 319.03M
Net Income Growth
-30.00% -20.62% +89.70% +3.95%
Net Margin Growth
+4.40% +3.30% +5.78% +5.87%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
203.83M 161.79M 306.91M 319.03M
Preferred Dividends
- - - -
-
Net Income Available to Common
203.83M 161.79M 306.91M 319.03M
EPS (Basic)
3.2996 2.6469 5.0273 5.5568
EPS (Basic) Growth
-29.67% -19.78% +89.93% +10.53%
Basic Shares Outstanding
61.77M 61.13M 61.05M 57.41M
EPS (Diluted)
3.2892 2.6329 4.9918 5.5081
EPS (Diluted) Growth
-29.56% -19.95% +89.59% +10.34%
Diluted Shares Outstanding
61.97M 61.45M 61.48M 57.92M
EBITDA
453.48M 457.38M 627.04M 701.98M
EBITDA Growth
-13.40% +0.86% +37.09% +11.95%
EBITDA Margin
+9.79% +9.33% +11.82% +12.92%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 105.00
Number of Ratings 2 Current Quarters Estimate 1.82
FY Report Date 12 / 2025 Current Year's Estimate 8.17
Last Quarter’s Earnings 1.62 Median PE on CY Estimate N/A
Year Ago Earnings 7.36 Next Fiscal Year Estimate 8.68
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate 1.82 2.02 8.17 8.68
High Estimates 1.89 2.03 8.24 8.91
Low Estimate 1.75 2.00 8.10 8.45
Coefficient of Variance 5.44 1.05 1.21 3.75

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 1 2 2
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Maximus Inc. - MMS

Date Name Shares Transaction Value
Mar 21, 2025 Jan Dutton Madsen Director 18,097 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $67.71 per share 1,225,347.87
Mar 14, 2025 John J. Haley Director 39,640 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 John J. Haley Director N/A Bona fide gift 0.00
Mar 14, 2025 John J. Haley Director 71,132 Bona fide gift 0.00
Mar 14, 2025 Michael J. Warren Director 15,355 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Anne K. Altman Director 32,032 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Gayathri Rajan Director 22,118 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Richard A. Montoni Director 67,500 Bona fide gift 0.00
Feb 21, 2025 Ilene Baylinson General Mgr - Health & Human 2,512 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $68.14 per share 171,167.68

Maximus Inc. in the News